OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
49
Results
Show all
Save search
Copy query
Show results for
Unknown
(48)
Transcriptomics
(1)
Organisms
Homo sapiens
(1)
Repository
biostudies-arrayexpress
(1)
Publication Date
2014
(1)
Study type
Transcription profiling by array
(1)
Release Date
2023
(7)
2025
(6)
2019
(6)
2022
(4)
2017
(4)
2014
(3)
2024
(3)
2021
(3)
2020
(2)
2015
(2)
2013
(2)
2010
(2)
2026
(1)
2018
(1)
2012
(1)
2011
(1)
2003
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort.
Not available
S-EPMC8487307
|
biostudies-literature
Cite
Human Whole Blood: Psoriatic Arthritis [PsA] vs. Cutaneous Psoriasis Without Arthritis [PsC] vs. Controls
Transcriptional profiling of human whole blood comparing PsA, PsC, and unaffected controls Three condition experiment: PsA, PsC, unaffected controls. Biological replicates: 20 PsA, 20 PsC, 12 controls
ORGANISM(S):
Homo sapiens
2014-09-24
|
E-GEOD-61281
|
biostudies-arrayexpress
Cite
Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials.
Not available
S-EPMC4225741
|
biostudies-literature
Cite
Interferon-α as a biomarker to predict renal outcomes in lupus nephritis.
Not available
S-EPMC11605838
|
biostudies-literature
Cite
Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis.
Not available
S-EPMC7728744
|
biostudies-literature
Cite
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status.
Not available
S-EPMC11557744
|
biostudies-literature
Cite
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis.
Not available
S-EPMC5561378
|
biostudies-literature
Cite
Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes.
Not available
S-EPMC12927393
|
biostudies-literature
Cite
Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis.
Not available
S-EPMC6350390
|
biostudies-literature
Cite
Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naive patients with active psoriatic arthritis (SPIRIT-P1).
Not available
S-EPMC6152421
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets